ArticleFrontiers in neurology2020
Diagnosing Autism Spectrum Disorder Without Expertise: A Pilot Study of 5- to 17-Year-Old Individuals Using Gazefinder.
Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 25 citations in OpenAlex.
- Trial
- Factors Associated With Professionals' Context-Specific Trust in AI-Based Screening for Autism Spectrum Disorder: Cross-Sectional Survey Study.JMIR formative research · 2026Article
- Early social gaze fixation and later inattention and hyperactivity-impulsivity symptoms in children: A longitudinal population-based cohort study.PCN reports : psychiatry and clinical neurosciences · 2026Article
- Classification of neurodevelopmental disorders and typical development using deep learning and a portable patch-type electroencephalography device.Neuroimage. Reports · 2026Article
- Adjunctive utility of gaze-based indices obtained with Gazefinder for ADHD assessment in children.European child & adolescent psychiatry · 2026Article
- Home-based eye tracking for early autism screening: a scoping review of approaches, evidence, and implementation challenges.BMC psychiatry · 2026Article
- Accuracy of a 2-minute eye-tracking assessment to differentiate young children with and without autism.Molecular autism · 2025Article
- Longitudinal association between the duration of eye gaze fixation on social information and specific symptoms of neurodevelopmental disorders in children: A large-scale community-based cohort study.PCN reports : psychiatry and clinical neurosciences · 2025Article
- Age of machine learning: new trends in autism spectrum disorder prediction.Frontiers in microbiology · 2025Review
- Feasibility of a 2-minute eye-tracking protocol to support the early identification of autism.Scientific reports · 2024Article
- Utilizing deep learning models in an intelligent eye-tracking system for autism spectrum disorder diagnosis.Frontiers in medicine · 2024Article
- Article
- Autism symptoms, functional impairments, and gaze fixation measured using an eye-tracker in 6-year-old children.Frontiers in psychiatry · 2023Article
- Machine learning-based early diagnosis of autism according to eye movements of real and artificial faces scanning.Frontiers in neuroscience · 2023Article
- Application of Eye Tracking Technology in Medicine: A Bibliometric Analysis.Vision (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 9 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atypical eye gaze is an established clinical sign in the diagnosis of autism spectrum disorder (ASD). We propose a computerized diagnostic algorithm for ASD, applicable to children and adolescents aged between 5 and 17 years using Gazefinder, a system where a set of devices to capture eye gaze patterns and stimulus movie clips are equipped in a personal computer with a monitor. We enrolled 222 individuals aged 5-17 years at seven research facilities in Japan. Among them, we extracted 39 individuals with ASD without any comorbid neurodevelopmental abnormalities (ASD group), 102 typically developing individuals (TD group), and an independent sample of 24 individuals (the second control group). All participants underwent psychoneurological and diagnostic assessments, including the Autism Diagnostic Observation Schedule, second edition, and an examination with Gazefinder (2 min). To enhance the predictive validity, a best-fit diagnostic algorithm of computationally selected attributes originally extracted from Gazefinder was proposed. The inputs were classified automatically into either ASD or TD groups, based on the attribute values. We cross-validated the algorithm using the leave-one-out method in the ASD and TD groups and tested the predictability in the second control group. The best-fit algorithm showed an area under curve (AUC) of 0.84, and the sensitivity, specificity, and accuracy were 74, 80, and 78%, respectively. The AUC for the cross-validation was 0.74 and that for validation in the second control group was 0.91. We confirmed that the diagnostic performance of the best-fit algorithm is comparable to the diagnostic assessment tools for ASD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.